Effect of point-of-care ultrasound on time to diagnosis among cancer survivors
Published
May 29, 2026
Paper ID
PAP-000098
Status
Published
DOI
10.65712/tmj.test000356
Advance Services
Abstract
Background: Earlier studies of point-of-care ultrasound were small or single-centre. Methods: The primary outcome was time to diagnosis, assessed blind to allocation. Results: The adjusted odds ratio was 0.82 (95% CI 0.30 to 0.70). Effects were consistent across prespecified subgroups. Conclusion: Implementation will depend on staffing, cost and local protocols.
Introduction
Guidelines make only a weak recommendation on point-of-care ultrasound. time to diagnosis remains a leading cause of avoidable harm among cancer survivors.
The cost of time to diagnosis to health systems is substantial. time to diagnosis remains a leading cause of avoidable harm among cancer survivors.
Materials and Methods
The primary outcome was time to diagnosis, assessed blind to allocation. Missing data were handled with multiple imputation. Analyses were adjusted for age, sex and baseline severity.
We conducted a quality-improvement audit across 8 centres between 2020 and 2021. We conducted a quality-improvement audit across 12 centres between 2018 and 2022.
We conducted a quality-improvement audit across 11 centres between 2019 and 2021. We conducted a quality-improvement audit across 3 centres between 2020 and 2022.
Results
The adjusted odds ratio was 0.91 (95% CI 0.40 to 0.82). Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.
time to diagnosis occurred in 5% of the intervention group versus 27% of controls. time to diagnosis occurred in 22% of the intervention group versus 25% of controls. Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % |
|---|---|---|---|
| Centre A | 537 | 89 | 16.8 |
| Centre A | 678 | 15 | 18.0 |
| Centre B | 53 | 78 | 7.9 |
| Age < 65 | 689 | 107 | 27.1 |
Values are n (%) unless stated otherwise.

Shown for cancer survivors; error bars are 95% confidence intervals.

Shown for cancer survivors; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.62 (95% CI 0.31 to 0.73). Effects were consistent across prespecified subgroups.
time to diagnosis occurred in 8% of the intervention group versus 28% of controls. Effects were consistent across prespecified subgroups.
Discussion
These findings suggest that point-of-care ultrasound is associated with better time to diagnosis in cancer survivors. Residual confounding cannot be excluded.
Implementation will depend on staffing, cost and local protocols. Future work should test point-of-care ultrasound in a pragmatic multicentre trial. These findings suggest that point-of-care ultrasound is associated with better time to diagnosis in cancer survivors.
Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. Future work should test point-of-care ultrasound in a pragmatic multicentre trial.
Conclusions
Point-of-care ultrasound merits wider use for cancer survivors to improve time to diagnosis.
References
1. Mueller P, Schmidt S, et al. Vitamin D supplementation and falls. Ann Intern Med. 2009;19(12):847-1466.
2. Rossi Y, Kim T, et al. Nurse-led discharge planning and emergency department revisits. Ann Intern Med. 2010;357(3):772-1327.
3. Dubois T, Costa Z, et al. Home-based cardiac rehabilitation and ventilator-free days. Eur Heart J. 2018;280(12):809-1475.
4. Costa D, Novak D, et al. An antibiotic stewardship programme and chronic pain scores. Crit Care Med. 2008;320(2):726-1428.
5. Andersen N, Osei F, et al. Low-dose aspirin and post-operative delirium. N Engl J Med. 2022;353(9):347-1583.
6. Kaur I, Patel I, et al. Continuous glucose monitoring and in-hospital mortality. Diabetes Care. 2008;332(7):801-1324.
7. Ahmed C, Costa V, et al. Nurse-led discharge planning and health-related quality of life. N Engl J Med. 2022;393(10):611-1525.
8. Moreau B, Volkov M, et al. Continuous glucose monitoring and acute kidney injury. BMC Med. 2025;232(1):545-1171.
9. Nasser J, Ibrahim E, et al. High-flow nasal oxygen and length of stay. N Engl J Med. 2018;253(8):387-1320.
Appendices
The statistical analysis plan is in the online supplement.